SC
Samlyn Capital’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,016,381
| Closed | -$34.1M | – | 93 |
|
|
2025
Q1 | $34.1M | Sell |
1,016,381
-1,457
| -0.1% | -$48.9K | 0.51% | 49 |
|
|
2024
Q4 | $39.9M | Sell |
1,017,838
-2,368
| -0.2% | -$92.8K | 0.6% | 53 |
|
|
2024
Q3 | $40.2M | Buy |
1,020,206
+380,521
| +59% | +$15M | 0.61% | 55 |
|
|
2024
Q2 | $24.9M | Buy |
639,685
+243,489
| +61% | +$9.49M | 0.42% | 64 |
|
|
2024
Q1 | $17.1M | Sell |
396,196
-24,959
| -6% | -$1.07M | 0.29% | 77 |
|
|
2023
Q4 | $19.4M | Sell |
421,155
-530,600
| -56% | -$24.4M | 0.39% | 57 |
|
|
2023
Q3 | $32.5M | Buy |
951,755
+11,846
| +1% | +$405K | 0.53% | 56 |
|
|
2023
Q2 | $36.2M | Sell |
939,909
-219,085
| -19% | -$8.43M | 0.61% | 50 |
|
|
2023
Q1 | $41.5M | Sell |
1,158,994
-34,820
| -3% | -$1.25M | 0.75% | 43 |
|
|
2022
Q4 | $47.1M | Sell |
1,193,814
-95,419
| -7% | -$3.76M | 0.92% | 36 |
|
|
2022
Q3 | $46.5M | Buy |
1,289,233
+172,797
| +15% | +$6.24M | 0.87% | 37 |
|
|
2022
Q2 | $34M | Buy |
1,116,436
+485,707
| +77% | +$14.8M | 0.68% | 41 |
|
|
2022
Q1 | $19.3M | Buy |
630,729
+109,089
| +21% | +$3.33M | 0.28% | 69 |
|
|
2021
Q4 | $16.3M | Buy |
+521,640
| New | +$16.3M | 0.22% | 73 |
|